Home > Resources > Company Profiles > Biovail Corp

Biovail Corp (BVF)

Your Name

Your Email Address *
Send a copy to me

Recipient's Email Address *

Separate multiple email addresses (max 20) with commas.

Subject *

Message

0/1500

Email Confirmation

Dr. Douglas J.P. Squires , CEO/Director/Chairman of the Board

www.biovail.com

Industry: Healthcare

OPEN

LAST

PREV CLOSE

CHANGE

VOLUME

Overview

News

People

Financials

Overview

A pharmaceutical company that applies advanced drug-delivery technologies to improve the clinical effectiveness of medicines and is engaged in the formulation, clinical testing, registration, manufacture and commercialization of pharmaceutical products.

Portfolio Articles

S.E.C. No Evil
Under chairman Christopher Cox, the commission has undermined and demoralized its enforcement staff. For the next administration, restoring the agency's role as market watchdog won't be easy.

Sep 18 2008
Biovail in Penalty Box
S.E.C. pursues four executives over accounting scheme.
Mar 24 2008

See more news on this company

News Feeds

Biovail faces lawsuit over depression drug AP
Oct 09 2008
Canadian drugmaker Biovail buys Prestwick Pharma AP
Sep 17 2008

Portfolio Blogs

The Biovail Blame Game Continues
Sep 11 2007

Press Releases

Biovail Comments on Filing of Lawsuit Oct-09-2008, 08:19AM EDT
Coughlin Stoia Geller Rudman & Robbins LLP Files Class Action Suit against Biovail Corporation Oct-09-2008, 08:00AM EDT
Biovail to Present at Natixis Bleichroeder Hidden Gems Conference Oct-07-2008, 03:15PM EDT
Biovail to Participate at Upcoming Investor Conferences Sep-18-2008, 03:45PM EDT
OVATION Pharmaceuticals Acquires Rights to Commercialize Xenazine(R) (Tetrabenazine) in U.S. for Chorea Associated with Huntington's Disease Sep-17-2008, 07:30AM EDT

News From Around the Web

News

Biovail responds to lawsuit (Mississauga News, Ontario)

Oct 11 2008
Coughlin Stoia Geller Rudman & Robbins LLP Files Class Action Suit... (MSN Money)

Oct 10 2008
Biovail faces suit (The Province, Canada)

Oct 10 2008
The Brualdi Law Firm, P.C. Announces Class Action Lawsuit Against Biovail Corporation (StreetInsider)

Oct 10 2008
Izard Nobel LLP Announces Class Action Lawsuit against Biovail Corporation (PharmaLive)

Oct 10 2008
Biovail faces new shareholders' class action suit (Vancouver Sun)

Oct 10 2008
Biovail facing shareholder suit (Calgary Herald)

Oct 10 2008
UPDATE 1-Biovail faces suit that it misled investors (Reuters)

Oct 09 2008
Class action securities suit filed against Biovail (MarketWatch)

Oct 09 2008
Biovail Comments on Filing of Lawsuit (MSN Money)

Oct 09 2008

Employees

Number of Employees: 1,533

Revenue per Employee: $443,016

Top Executives

John Sebben, Vice President, Divisional

Wendy A. Kelley, Senior VP/General Counsel/Secretary

Adrian de Saldanha, Vice President, Divisional/Treasurer

Gregory Gubitz, Senior VP, Divisional

John R. Miszuk, Vice President/Controller/Assistant Secretary

Christopher Bovaird, Vice President, Divisional

Michel Chouinard, COO, Subsidiary

Mark Durham, Senior VP, Divisional

Kathleen Brown, Vice President/Other Executive Officer/Other Corporate Officer

Gilbert Godin, COO/Executive VP

Christine C. Mayer, Senior VP, Subsidiary

Scott Smith, Vice President, Subsidiary/General Manager, Subsidiary

Kenneth G. Howling, Senior VP/CFO

Board of Directors

William (Bill) Wells, Director

Jamie C. Sokalsky, Director

Dr.Laurence E. Paul, MD, Director

John R. Miszuk, Vice President/Controller/Assistant Secretary

Wendy A. Kelley, Senior VP/General Counsel/Secretary

Adrian de Saldanha, Vice President, Divisional/Treasurer

Michael R. Van Every, Director

Wilfred G. Bristow, Director

Lloyd M. Segal, Director

Financials

Quarterly

Annual

Income Statement	09/2008	05/2008	03/2008	11/2007
Sales	30.09 Mil.	40.23 Mil.	46.74 Mil.	44.69 Mil.
Gross Operating Profit	156 Mil.	168.27 Mil.	157.15 Mil.	144.2 Mil.
Operating Income before D & A (EBITDA)	77.61 Mil.	88.34 Mil.	96.46 Mil.	79.86 Mil.
Total Income Before Interest Expenses (EBIT)	-19.45 Mil.	62.02 Mil.	-30.9 Mil.	69.61 Mil.
Total Net Income	-25.29 Mil.	56.38 Mil.	-31.97 Mil.	65.87 Mil.
Basic EPS, Total	-0.16	0.35	-0.19	0.41
Diluted EPS, Total	-0.16	0.35	-0.19	0.41

BALANCE STATEMENT	09/2008	05/2008	03/2008	11/2007
Cash and Equivalents	354.06 Mil.	431.54 Mil.	433.64 Mil.	411.91 Mil.
Total Assets	664.06 Mil.	735.22 Mil.	707.02 Mil.	615.01 Mil.
Total Liabilities	350.98 Mil.	390.22 Mil.	367.58 Mil.	228.44 Mil.
Total Capitalization	1.18 Bil.	1.29 Bil.	1.3 Bil.	1.38 Bil.

Cash Flow	09/2008	05/2008	03/2008	11/2007
Net Cash From Continuing Operations	159.73 Mil.	92.68 Mil.	340.85 Mil.	261.52 Mil.
Net Cash From Investing Activities	-92.48 Mil.	-94.28 Mil.	-15.04 Mil.	-16.54 Mil.
Net Cash From Financing Activities	-146.46 Mil.	-138 K.	-728.65 Mil.	-668.21 Mil.
Net Change in Cash & Cash Equivalents	-79.58 Mil.	-2.1 Mil.	-400.9 Mil.	-422.63 Mil.

Income Statement	2008	2007	2006	2005
Sales	170.96 Mil.	171.86 Mil.	161.78 Mil.	197.98 Mil.
Gross Operating Profit	671.86 Mil.	898.62 Mil.	773.76 Mil.	688.56 Mil.
Operating Income before D & A (EBITDA)	392.74 Mil.	564.71 Mil.	453.76 Mil.	341.51 Mil.
Total Income Before Interest Expenses (EBIT)	218.48 Mil.	257.49 Mil.	158.87 Mil.	102.48 Mil.
Total Net Income	195.54 Mil.	203.94 Mil.	89.03 Mil.	52.75 Mil.
Basic EPS, Total	1.22	1.27	0.56	0.33
Diluted EPS, Total	1.22	1.27	0.56	0.33

BALANCE STATEMENT	2008	2007	2006	2005
Cash and Equivalents	433.64 Mil.	834.5 Mil.	445.29 Mil.	34.32 Mil.
Total Assets	707.02 Mil.	1.06 Bil.	684.79 Mil.	314.66 Mil.
Total Liabilities	367.58 Mil.	410.27 Mil.	273.56 Mil.	190.24 Mil.
Total Capitalization	1.3 Bil.	1.69 Bil.	1.79 Bil.	1.8 Bil.

Cash Flow	2008	2007	2006	2005
Net Cash From Continuing Operations	340.85 Mil.	518.64 Mil.	501.88 Mil.	277.09 Mil.
Net Cash From Investing Activities	-15.04 Mil.	-40.44 Mil.	31.78 Mil.	-42.26 Mil.
Net Cash From Financing Activities	-728.65 Mil.	-92.25 Mil.	-119.1 Mil.	-334.53 Mil.
Net Change in Cash & Cash Equivalents	-400.9 Mil.	389.23 Mil.	410.96 Mil.	-98.94 Mil.

Biovail Corp (BVF)

Company Information

Overview

Employees

Top Executives

Board of Directors

Financials

Company Profile Change Request